Presentation Material : Business Strategy Briefing 2026NEW

About this update from Mitsubishi Chemical Group Corporation

Mitsubishi Chemical Group Business Strategy Briefing 2026 May 25, 2026 Manabu Chikumoto President & Chief Executive Officer Mitsubishi Chemical Group Corporation FY25 Review FY26 Outlook: From Defense to Offense 2 FY26 Business Strategy Agenda FY25 Review FY25 results Final phase of structural reform Foundations for growth beyond FY26 FY26 Outlook: From Defense to Offense 3 FY26 Business Strategy Agenda FY25 results: Group core operating income FY25 results in the Chemicals business were challenging due to the recognition of an impairment loss on fixed assets related to Soarnol in the UK and deterioration in MMA monomer market conditions, but Industrial Gases remained solid, resulting in performance broadly in line with the previous fiscal year. Continue to focus on accelerating growth in Specialty Materials and restructuring the materials business to deliver FY29 target Mitsubishi Chemical Group Core operating income (Oku yen) Chemicals Industrial Gases Chemicals Industrial Gases Core operating margin 10 % Mitsubishi Chemical Group Core operating income margin 230 2,120 4,600 Core operating margin 6 % 2,288 Core operating margin 2,360 6 % 2,250 1,479 427 243 -151 FY23 *1 FY24 *1 FY25 FY29 Target Mitsubishi Chemical Group Corporation *1 Adjusted by reclassifying Pharma as a discontinued business FY25 results and FY26 forecast: Specialty Materials Core operating 10 % margin In FY25, an impairment loss of approximately 30 billion yen was recognized following the review of the UK Soarnol investment plan. Specialty Materials *1 remained generally solid excluding this impact, reaching a level close to the forecast (65 billion yen *2 ). In FY26, Specialty Materials *2 is expected to make steady progress in strengthening its revenue base and achieve business growth through the continued execution of three key initiatives, in addition to the results achieved through the structural reform implemented over the past two years. FY25 FY26 Specialty Materials Core operating income (Oku yen) *2 Core Core operating margin FY27-FY29 Key initiatives Realization of investment effects Specialty Materials Impairment loss on Soarnol-related fixed assets in the U.K. (303) Core operating income margin Core operating margin 323 2 % Absence of the impact of an impairment loss on Soarnol-related fixed assets in the U.K. 220 Core operating margin 3 % operating margin 4 % 303 8 % 900 △157 305 Higher fixed costs and other factors Contribution from the "Three disciplined approaches in business operations" *5 1550 FY23 FY24 Contribution from 239 the "Three disciplined approaches in business operations" *5 74 449 FY25 FY25 *4 FY26 FY29 Before organizational Structure change After organizational structure change Forecast *4 Target *4 *1 Advanced Films & Polymers, Advanced Solutions, Advanced Composite & Shapes *2 Earnings forecast announced on October 31, 2025 *3 Films & Performance Materials, Composites & Shapes. Information Electronics, Polymer Compounds, Water & Infrastructure Mitsubishi Chemical Group Corporation *4 Figures are presented based on reclassified reporting segment categories applicable from FY26 onward, in line with the organizational restructuring effective April 1, 2026. *5 Excluding effects arising in the Corporate sector

View stock analysis, news, and events for Mitsubishi Chemical Group Corporation